Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2013-02-05

FDA Approved: ALENDRONATE SODIUM — Supplemental Application (Aurobindo Pharma Limited)

View source ↗

Summary

FDA approved a supplemental application for a generic alendronate sodium product from Aurobindo Pharma Limited (ANDA 090124). The approval adds a new generic op…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ALENDRONATE SODIUM (ALENDRONATE SODIUM)

Snippet

SUPPL AP for ALENDRONATE SODIUM (ALENDRONATE SODIUM)